Author: Takamatsu N. Welage L.S. Hayashi Y. Yamamoto R. Barnett J.L. Shah V.P. Lesko L.J. Ramachandran C. Amidon G.L.
Publisher: Elsevier
ISSN: 0939-6411
Source: European Journal of Pharmaceutics and Biopharmaceutics, Vol.54, Iss.2, 2002-09, pp. : 255-255
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Takamatsu N. Welage L.S. Hayashi Y. Yamamoto R. Barnett J.L. Shah V.P. Lesko L.J. Ramachandran C. Amidon G.L.
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 53, Iss. 1, 2002-01 ,pp. :
By Cavallari C. Albertini B. Gonzalez-Rodrguez M.L. Rodriguez L.
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 3, 2002-11 ,pp. :
By Heller J. Barr J. Ng S.Y. Shen H.-R. Schwach-Abdellaoui K. Einmahl S. Rothen-Weinhold A. Gurny R.
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. :
By Mortensen M. Frolund B. Jorgensen A.T. Liljefors T. Krogsgaard-Larsen P. Ebert B.
European Journal of Pharmacology, Vol. 453, Iss. 2, 2002-10 ,pp. :
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. :